Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

• Published in: Endocrine Vol. 67; no. 1; pp. 1 - 8
• Main Authors: Paschou, Stavroula A., Polyzos, Stergios A., Anagnostis, Panagiotis, Goulis, Dimitrios G., Kanaka-Gantenbein, Christina, Lambrinoudaki, Irene, Georgopoulos, Neoklis A., Vryonidou, Andromachi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.01.2020; Springer Nature B.V
• Subjects: Body weight loss; Diabetes; Diabetes mellitus (non-insulin dependent); Endocrinology; Fatty liver; Humanities and Social Sciences; Insulin; Internal Medicine; Liver diseases; Medicine; Medicine & Public Health; multidisciplinary; Obesity; Polycystic ovary syndrome; Review; Science; Weight control; Polycystic ovary syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Ovaries, Hyperandrogenism, Insulin resistance, Metabolic syndrome

Polycystic ovary syndrome (PCOS) affects 6–15% of women of reproductive age. Nonalcoholic fatty liver disease (NAFLD) affects 25–30% of the general population and its prevalence increases in parallel with the epidemics of obesity and type 2 diabetes mellitus. A growing body of evidence suggests that...